Clinical outcomes of radical radiotherapy for pulmonary sarcomatoid carcinoma.

ABSTRACT:

Purpose

Pulmonary sarcomatoid carcinoma (PSC) is recognized for its aggressiveness and poor prognosis. The role of radical radiotherapy in PSC remains uncertain due to its scarcity and limited data. In the absence of an effective systemic agent, this study aims to explore the possibility of cure and to investigate potential prognostic factors and treatment outcomes.

Materials and methods

From January 2005 to December 2021, 149 PSC patients were identified. Among 62 patients who received radiotherapy for lung lesions, 25 who underwent palliative radiotherapy and 16 who underwent surgery were excluded.

Results

The median patient age was 71 years. The majority were male, and 17 patients (81.0%) were diagnosed at an advanced stage. After radical radiotherapy, distant meta

SUBMITTER: Lee CW 

PROVIDER: S-EPMC10556836 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature